Skip to Content

M RE 150 (Risedronate Sodium 150 mg)

Pill with imprint M RE 150 is Blue, Round and has been identified as Risedronate Sodium 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Risedronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M RE 150

Risedronate sodium 150 mg M RE 150

Risedronate Sodium

Imprint:
M RE 150
Strength:
150 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4150

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide